1. Home
  2. CRVS vs ARI Comparison

CRVS vs ARI Comparison

Compare CRVS & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.09

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$10.65

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
ARI
Founded
2014
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2016
2009

Fundamental Metrics

Financial Performance
Metric
CRVS
ARI
Price
$14.09
$10.65
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$28.20
$11.00
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
03-12-2026
04-23-2026
Dividend Yield
N/A
9.41%
EPS Growth
48.04
183.51
EPS
N/A
0.81
Revenue
N/A
$271,589,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.14
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$7.70
52 Week High
$26.95
$11.21

Technical Indicators

Market Signals
Indicator
CRVS
ARI
Relative Strength Index (RSI) 40.37 54.99
Support Level $6.65 $9.60
Resistance Level $18.73 $10.95
Average True Range (ATR) 0.95 0.22
MACD -0.21 0.02
Stochastic Oscillator 27.18 84.62

Price Performance

Historical Comparison
CRVS
ARI

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: